The CHA PGY2 Ambulatory Care Pharmacy Residency program anticipates a July 2025 start and is currently in the pre-candidacy status through the American Society of Health-System Pharmacists (ASHP).
Program Purpose
The CHA PGY2 ambulatory care pharmacy residency program builds on Doctor of Pharmacy (Pharm.D.) education and PGY1 pharmacy residency training and outcomes to contribute to the development of clinical pharmacists who:
- Are responsible for patient care in the advanced practice setting of ambulatory care
- Are eligible for ambulatory care pharmacist board certification
Overview and Application Process
The PGY2 ambulatory care pharmacy residency program recruits one (1) resident annually.
Applications are accepted through the Pharmacy Online Residency Centralized Application Service (PhORCAS).
We participate in the National Matching Services Program.
All offers of appointment to CHA sponsored training programs are specifically conditioned upon a criminal background investigation and a negative drug test (uses workplace standards, including chain of custody, marijuana is excluded from the testing). Background checks will be carried out by an agency on behalf of CHA. By signing the background check release form, prospective trainees are consenting to a background investigation. The drug test must be completed within 10 days of matching (all costs are covered by CHA). It will be conducted at CHA Occupational Health for those residents within 20 miles of Boston. All others will be tested at an outside facility arranged by CHA.
Residency Policies
Resident Guide Program
Residents will meet monthly with a group of pharmacists who have completed PGY-1 and/or PGY-2 residencies but have not yet become formal program preceptors. These pharmacists serve as a resource and will conduct monthly workshops for residents. Please see this PDF for more detailed information on the PGY1 Pharmacy Residency Guide Role.
Residency Handbook
In our Pharmacy Residency Handbook you can learn more about: CHA and our Pharmacy Enterprise; Residency Program Overview and Requirements; Residency Policies and Procedures and Residency Resources.
Learning Experience Offerings
Required
Orientation
Primary Care I-IV
Anticoagulation
Practice Management
Population Health
Behavioral Health
Pulmonology
Infectious Disease
Staffing (Resident-led Clinic)
Clinical On-call (anticoagulation)
Elective
Diabetes Technology
Cardiology
Team-based Care w/ SDOH Focus*
Informatics
Public Health*
Academia
Potential for repeat of required experiences
*in development
Academia and Longitudinal Projects
Protocol Development
ACPE CE Lecture
Research Project
Pharmacy Leadership Forum
Inservices
Case Conference
Teaching Certificate Program (optional)
PGY2 Ambulatory Care Pharmacy Residency General Information
Stipend: $63,000
Number of positions: 1
Accreditation Status: The PGY2 ambulatory care pharmacy residency program at CHA is currently under the pre-candidacy status by the American Society of Health-System Pharmacists (ASHP).
Application Process: Applications accepted through the Pharmacy Online Residency Centralized Application Service (PhORCAS)
Application Deadline: 1/2/26
Application Materials
Internal PGY1 residents may be considered for early commitment. Please contact the Residency Program Director for additional information. All other applicants are required to participate through the National Matching Services Program. We require the standard PGY2 PhORCAS application materials which include:
- PGY2 PhORCAS application
- Personal Statement (Letter of Intent)
- Curriculum Vitae (CV)
- Official College of Pharmacy Transcript
- Three letters of recommendations using the PhORCAS standard reference template
We do not require any additional supplemental materials. However, we encourage you to include the following:
- Letters of Recommendation: Three required letters with at least one from a clinical preceptor
- Rotation Descriptions on CV: include the preceptor name(s) and highlight your responsibilities (e.g., pharmacist protocol management, note writing, patient counseling, pharmacokinetic monitoring)
- Residency Program Director: Garrett Lech, PharmD, BCACP, DPLA. Please contact him with any questions about the PGY2 Ambulatory Care Residency Program